• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善囊性纤维化患者的营养状况:系统文献回顾。

Improving nutrition in cystic fibrosis: A systematic literature review.

机构信息

Cystic Fibrosis Department, Institute of Mother and Child, Warsaw, Poland; Cystic Fibrosis Centre, Pediatric Hospital, Dziekanów Leśny, Poland.

Cystic Fibrosis Department, Institute of Mother and Child, Warsaw, Poland; Cystic Fibrosis Centre, Pediatric Hospital, Dziekanów Leśny, Poland.

出版信息

Nutrition. 2022 Oct;102:111725. doi: 10.1016/j.nut.2022.111725. Epub 2022 May 6.

DOI:10.1016/j.nut.2022.111725
PMID:35816813
Abstract

With increasing life expectancy of patients with cystic fibrosis (CF), gastrointestinal manifestations of the disease have been increasingly brought into focus. This was a systematic review of the PubMed database and ongoing phase III clinical trials that aimed to summarize recent (published after June 1 2016) studies reporting the effects of nutritional interventions on anthropometric measures (weight, height, and body mass index) in patients with CF. Two ongoing trials and 40 published studies (18 interventional and 22 observational) were identified. Key results supported the benefits of comprehensive, individualized nutritional plans, high-fat, high-calorie diet including high-quality carbohydrates, and enteric tube feeding (albeit the latter was derived from observational studies only). In contrast, the supplementation of probiotics, lipids, docosahexaenoic, glutathione, or antioxidant-enriched multivitamin appeared to have little effect on anthropometric measures.

摘要

随着囊性纤维化 (CF) 患者预期寿命的延长,其胃肠道表现已越来越受到关注。这是对 PubMed 数据库和正在进行的 III 期临床试验的系统回顾,旨在总结最近(发表于 2016 年 6 月 1 日之后)报道营养干预对 CF 患者人体测量指标(体重、身高和体重指数)影响的研究。确定了两项正在进行的试验和 40 项已发表的研究(18 项干预性和 22 项观察性)。主要结果支持综合、个体化营养计划、高脂肪、高热量饮食(包括高质量碳水化合物)和肠内喂养(尽管后者仅来自观察性研究)的益处。相比之下,益生菌、脂质、二十二碳六烯酸、谷胱甘肽或富含抗氧化剂的多种维生素补充剂似乎对人体测量指标没有影响。

相似文献

1
Improving nutrition in cystic fibrosis: A systematic literature review.改善囊性纤维化患者的营养状况:系统文献回顾。
Nutrition. 2022 Oct;102:111725. doi: 10.1016/j.nut.2022.111725. Epub 2022 May 6.
2
Recombinant growth hormone therapy for cystic fibrosis in children and young adults.儿童和青年囊性纤维化患者的重组人生长激素治疗。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD008901. doi: 10.1002/14651858.CD008901.pub5.
3
Oral protein calorie supplementation for children with chronic disease.对患有慢性病的儿童进行口服蛋白质热量补充。
Cochrane Database Syst Rev. 2000(3):CD001914. doi: 10.1002/14651858.CD001914.
4
Short-acting inhaled bronchodilators for cystic fibrosis.短效吸入性支气管扩张剂在囊性纤维化中的应用。
Cochrane Database Syst Rev. 2022 Jun 24;6(6):CD013666. doi: 10.1002/14651858.CD013666.pub2.
5
Nebulised hypertonic saline for cystic fibrosis.雾化高渗盐水用于囊性纤维化
Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD001506. doi: 10.1002/14651858.CD001506.pub4.
6
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
7
Enteral tube feeding for cystic fibrosis.囊性纤维化的肠内管饲法。
Cochrane Database Syst Rev. 2000(2):CD001198. doi: 10.1002/14651858.CD001198.
8
Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.预防囊性纤维化患者远端肠梗阻综合征(DIOS)的干预措施。
Cochrane Database Syst Rev. 2018 Jun 12;6(6):CD012619. doi: 10.1002/14651858.CD012619.pub2.
9
Enteral tube feeding for people with severe dementia.经口肠内营养管饲用于重度痴呆患者。
Cochrane Database Syst Rev. 2021 Aug 13;8(8):CD013503. doi: 10.1002/14651858.CD013503.pub2.
10
Physical activity and exercise training in cystic fibrosis.囊性纤维化中的体力活动和运动训练。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD002768. doi: 10.1002/14651858.CD002768.pub5.

引用本文的文献

1
Glucagon-Like Peptide 1 Agonist Use in an Adult With Cystic Fibrosis-Related Diabetes and Metabolic Syndrome.胰高血糖素样肽1激动剂在一名患有囊性纤维化相关糖尿病和代谢综合征的成人中的应用。
AACE Endocrinol Diabetes. 2025 Apr 11;12(2):67-70. doi: 10.1016/j.aed.2025.03.011. eCollection 2025 Jul-Aug.
2
Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study.低升糖负荷饮食干预对成年囊性纤维化患者的安全性和耐受性:一项试点研究。
Front Nutr. 2024 Sep 25;11:1441201. doi: 10.3389/fnut.2024.1441201. eCollection 2024.
3
Global Leadership Initiative on Malnutrition-Diagnosed Malnutrition in Lung Transplant Candidates.
全球营养不良领导倡议-肺移植候选者的营养不良诊断。
Nutrients. 2024 Jan 27;16(3):376. doi: 10.3390/nu16030376.
4
What the future holds: cystic fibrosis and aging.未来的发展:囊性纤维化与衰老
Front Med (Lausanne). 2024 Jan 8;10:1340388. doi: 10.3389/fmed.2023.1340388. eCollection 2023.
5
A Systematic Review of the Effect of Cystic Fibrosis Treatments on the Nasal Potential Difference Test in Animals and Humans.囊性纤维化治疗对动物和人类鼻电位差测试影响的系统评价
Diagnostics (Basel). 2023 Sep 29;13(19):3098. doi: 10.3390/diagnostics13193098.